Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical ...

) has been revised to $7.65 / share. This is a decrease of 14.29% from the prior estimate of $8.92 dated December 3, 2025. The price target is an average of many targets provided by analysts. The ...

) has been revised to $8.92 / share. This is a decrease of 27.08% from the prior estimate of $12.24 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...

Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...

(RTTNews) - Shares of medical device company Microbot Medical Inc. (MBOT) jumped more than 70% on Monday after the Company announced that it would be unveiling LIBERTY, the world's first fully ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Microbot Medical Inc. (NASDAQ:MBOT) is one of the best-performing NASDAQ stocks according to analysts. On June 17, Microbot Medical announced that it had been granted a patent in China by the China ...